Mirhosseini, N., Mirhosseini, S. (2023). A Case Report of Down Syndrome and β-Thalassemia Major Coincidence. Shahid Sadoughi University of Medical Sciences- Journal Management System, 6(1), 61-63. doi: 10.18502/wjpn.v6i1.14254
Naser Ali Mirhosseini; Shima Mirhosseini. "A Case Report of Down Syndrome and β-Thalassemia Major Coincidence". Shahid Sadoughi University of Medical Sciences- Journal Management System, 6, 1, 2023, 61-63. doi: 10.18502/wjpn.v6i1.14254
Mirhosseini, N., Mirhosseini, S. (2023). 'A Case Report of Down Syndrome and β-Thalassemia Major Coincidence', Shahid Sadoughi University of Medical Sciences- Journal Management System, 6(1), pp. 61-63. doi: 10.18502/wjpn.v6i1.14254
Mirhosseini, N., Mirhosseini, S. A Case Report of Down Syndrome and β-Thalassemia Major Coincidence. Shahid Sadoughi University of Medical Sciences- Journal Management System, 2023; 6(1): 61-63. doi: 10.18502/wjpn.v6i1.14254
A Case Report of Down Syndrome and β-Thalassemia Major Coincidence
1Children Growth Disorder Research Center, Shahid Sadoughi Hospital, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2Department of Pediatrics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3Mother and Newborn Health Research Center, Shahid Sadoughi Hospital, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4Department of Biology, Faculty of Science, Yazd University, Yazd, Iran
Abstract
Background: Down syndrome and β-thalassemia are commonly prevalent genetic diseases worldwide. Predominantly, an extra copy of chromosome 21 or trisomy 21 predominantly causes Down syndrome (the most common genetic etiology of moderate intellectual disability). Down syndrome is associated with congenital anomalies and characteristic features. β-thalassemia major or transfusion- dependent Thalassemia refers to a severe expression of the disorder that requires early transfusion therapy. Case Report: Here, we reported a male Down syndrome patient with a 47, xy, +21 karyotype who was diagnosed with β-thalassemia major at 6 months and treated with repeated transfusions every 20 days due to anemia. Conclusion: The association between Down syndrome and major β-thalassemia is rare. The severity of the presentation of the child may be explained by the coincidence of these diseases.
Lankeshwar-Gajbhiye N, Gaitonde R. Epidemiology of down’s syndrome & Β-thalassemia in India. Int J Res 2022; 10(2): 145-51.
Roodpeyma S, Behjati F, Shiva F. Congenital anomalies in newborns: Review article. SJMR 2021; 6(2): 125-33.
Garg A, Singh A, Ramachandran M, Kapoor S. Down syndrome with transient myeloproliferative disorder and beta-thalassemia major. Indian J Hematol Blood Transfus 2014; 30(Suppl 1): 205.
Kliegman RM, Geme JW. Nelson textbook of pediatrics. 21st Philadelphia. PA: Elsevier; 2020. p. 659.
Benhaourech S, Drighil A, El Hammiri A. Congenital heart disease and Down syndrome: various aspects of a confirmed association. Cardiovasc J Afr 2016; 27(5): 287-90.
Elmagrpy Z, Rayani A, Shah A, Habas E, Aburawi EH. Down syndrome and congenital heart disease: why the regional difference as observed in the libyan experience? Cardiovasc J Afr 2011; 22(6): 306-9.
Abdulrazzaq Y, El-Azzabi TI, Al Hamad SM, Attia S, Deeb A, Aburawi EH. Occurrence of hypothyroidism, diabetes mellitus, and celiac disease in emirati children with Down’s syndrome. Oman Med J 2018; 33(5): 387-92.
Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, et al. Down syndrome. Nat Rev Dis Prim 2020; 6(1): 9.
Stanley MA, Shepherd N, Duvall N, Jenkinson SB, Jalou HE, Givan DC, et al. Clinical identification of feeding and swallowing disorders in 0-6 month old infants with Down syndrome. Am J Med Genet A 2019; 179(2): 177-82.
Coentro VS, Geddes DT, Perrella SL. Altered sucking dynamics in a breastfed infant with Down syndrome: a case report. Int Breastfeed J 2020; 15(1): 71.
Bittles A, Glasson EJ. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol 2004; 46(4): 282-6.
Banerjee P, Thapa R. Beta-thalassemia major and Down’s syndrome. J Paediatr Child Health 2008; 44(7-8): 472-3.
Palomo-Colli MA, Zapata-Tarres M, Castelán-Martínez OD, Juárez-Villegas LE, Córdova-Hurtado LP. A strategy for the clinical remission of acute lymphoblastic leukemia elicited by treatment of β-thalassemia major: A case report. Mol Clin Oncol 2018; 8(2): 375-7.
Keser I, Canatan D, Güzeloglu-Kayişli Ö, Coşan R, Lüleci G. Beta-Thalassemia major associated with Down syndrome. Ann Genet 2001; 44(2): 57-8.
Tenenbaum A, Malkiel S, Wexler ID, Levy-Khademi F, Revel-Vilk S, Stepensky P. Anemia in children with down syndrome. Int J Pediatr 2011; 2011: 813541.
